United States Pharmaceuticals

Pacira Biosciences Inc (PCRX)

Track

Pacira Biosciences experienced significant insider trading activity over the past ninety days, characterized exclusively by sales. Executives and directors offloaded shares totaling approximately 954,715 dollars. These divestments occurred amidst a six percent stock price increase, following positive results financiers reported in August.
Ticker: PCRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Pacira Biosciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ceesay Abraham Director Non-Executive Director
Transaction date
Proposed sale
Price
18.82
Quantity 57,431
Value US$3,822,308
3.5
RIKER LAUREN Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
451.07
Quantity 14,565 +5.3%
Value US$632,944
3.5
RIKER LAUREN Officer Officer
Transaction date
Proposed sale
Price
15.98
Quantity 14,853
Value US$936,686
3.2
WILLIAMS KRISTEN Chief Administrative Officer Officer
Transaction date
Planned sale
Price
22.27
Quantity 10,259 -5.8%
Value US$228,468
3.2
WILLIAMS KRISTEN Officer Officer
Transaction date
Proposed sale
Price
22.27
Quantity 10,259
Value US$228,468
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.16
Quantity 12,941 -10.9%
Value US$325,596
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
25.16
Quantity 12,941
Value US$325,576
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.01
Quantity 1,500 -1.4%
Value US$37,515
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
25.01
Quantity 1,500
Value US$37,520
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.01
Quantity 2,845 -2.6%
Value US$71,153
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
25.01
Quantity 2,845
Value US$71,149
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.14
Quantity 7,714 -6.8%
Value US$193,930
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
25.14
Quantity 7,714
Value US$193,912
3.2
Froimson Mark Non-Executive Director
Transaction date
Sale
Price
21.81
Quantity 500 -2.4%
Value US$10,905
3.5
SLONIN JONATHAN Chief Medical Officer Officer
Transaction date
Planned sale
Price
22.82
Quantity 3,261 -1.4%
Value US$74,416
3.2
Froimson Mark Director Non-Executive Director
Transaction date
Proposed sale
Price
21.81
Quantity 500
Value US$10,905
3.5
SLONIN JONATHAN Officer Officer
Transaction date
Proposed sale
Price
22.82
Quantity 3,261
Value US$74,416
3.2
WILLIAMS KRISTEN Chief Administrative Officer Officer
Transaction date
Planned sale
Price
20.53
Quantity 13,137 -9.1%
Value US$269,703
3.5
RIKER LAUREN Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
20.81
Quantity 4,000 -7.1%
Value US$83,240
3.2
WILLIAMS KRISTEN Chief Administrative Officer Officer
Transaction date
Planned sale
Price
20.53
Quantity 13,137 -9.1%
Value US$269,703
3.5
RIKER LAUREN Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
20.81
Quantity 4,000 -7.1%
Value US$83,240
3.5
RIKER LAUREN Officer Officer
Transaction date
Proposed sale
Price
21.05
Quantity 4,000
Value US$84,219
3.2
WILLIAMS KRISTEN Officer Officer
Transaction date
Proposed sale
Price
20.53
Quantity 13,137
Value US$269,703
3.5
RIKER LAUREN Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
24.24
Quantity 1,416 -2.3%
Value US$34,324
3.5
RIKER LAUREN Officer Officer
Transaction date
Proposed sale
Price
24.24
Quantity 1,416
Value US$34,324
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.14
Quantity 9,104 -13.9%
Value US$228,875
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
25.14
Quantity 9,104
Value US$228,912
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
25.03
Quantity 15,896 -22.0%
Value US$397,877
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
25.03
Quantity 15,896
Value US$397,837
3.5
SLONIN JONATHAN Chief Medical Officer Officer
Transaction date
Planned sale
Price
24.09
Quantity 3,960 -2.2%
Value US$95,396
3.5
SLONIN JONATHAN Officer Officer
Transaction date
Proposed sale
Price
24.09
Quantity 3,960
Value US$95,396
Cross Shawn Chief Financial Officer Officer
Transaction date
Planned sale
Price
22.09
Quantity 12,060 -17.7%
Value US$266,405
Cross Shawn Officer Officer
Transaction date
Proposed sale
Price
22.09
Quantity 12,060
Value US$266,405
Ceesay Abraham Non-Executive Director
Transaction date
Planned sale
Price
27.19
Quantity 2,354 -20.7%
Value US$64,005
Ceesay Abraham Director Non-Executive Director
Transaction date
Proposed sale
Price
27.19
Quantity 2,354
Value US$64,005
2.8
BIGAL MARCELO Non-Executive Director
Transaction date
Sale
Price
23.67
Quantity 4,912 -30.1%
Value US$116,267
2.8
BIGAL MARCELO Director Non-Executive Director
Transaction date
Proposed sale
Price
23.67
Quantity 4,912
Value US$116,279
3.5
RIKER LAUREN Senior Vice President, Finance Officer
Transaction date
Sale
Price
26.21
Quantity 5,578 -8.6%
Value US$146,208
3.2
WILLIAMS KRISTEN Chief Administrative Officer Officer
Transaction date
Sale
Price
26.24
Quantity 14,376 -8.2%
Value US$377,226
3.5
RIKER LAUREN Officer Officer
Transaction date
Proposed sale
Price
26.21
Quantity 5,579
Value US$146,209
3.2
WILLIAMS KRISTEN Officer Officer
Transaction date
Proposed sale
Price
26.24
Quantity 14,376
Value US$377,226
3.4
GAUGLER DARYL Officer Officer
Transaction date
Proposed sale
Price
23.25
Quantity 500
Value US$11,625
3.5
SLONIN JONATHAN Officer Officer
Transaction date
Proposed sale
Price
18.40
Quantity 879
Value US$16,174
3.5
SLONIN JONATHAN Chief Medical Officer Officer
Transaction date
Planned sale
Price
18.40
Quantity 879 -0.9%
Value US$16,174
3.4
GAUGLER DARYL Chief Operating Officer Officer
Transaction date
Planned sale
Price
19.76
Quantity 500 -0.4%
Value US$9,880
3.4
GAUGLER DARYL Officer Officer
Transaction date
Proposed sale
Price
19.76
Quantity 500
Value US$9,880
3.4
GAUGLER DARYL Officer Officer
Transaction date
Proposed sale
Price
12.86
Quantity 500
Value US$6,430
3.4
GAUGLER DARYL Chief Operating Officer Officer
Transaction date
Planned sale
Price
12.86
Quantity 500 -0.4%
Value US$6,430
3.1
Brege Laura Non-Executive Director
Transaction date
Purchase
Price
12.81
Quantity 1,000 +6.0%
Value US$12,810
2.8
BIGAL MARCELO Non-Executive Director
Transaction date
Purchase
Price
13.25
Quantity 1,512 +17.5%
Value US$20,034
3.3
YANG MICHAEL J. Non-Executive Director
Transaction date
Purchase
Price
12.90
Quantity 2,000 +38.2%
Value US$25,800
3.7
Lee Frank D. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
12.10
Quantity 8,264 +8.3%
Value US$99,994
3.2
Froimson Mark Non-Executive Director
Transaction date
Purchase
Price
11.58
Quantity 1,400 +10.7%
Value US$16,212
2.8
BIGAL MARCELO Non-Executive Director
Transaction date
Purchase
Price
12.01
Quantity 3,400 +65.0%
Value US$40,834
3.5
SLONIN JONATHAN Officer Officer
Transaction date
Proposed sale
Price
20.05
Quantity 945
Value US$18,947
3.5
SLONIN JONATHAN Chief Medical Officer Officer
Transaction date
Planned sale
Price
20.05
Quantity 945 -1.0%
Value US$18,947
3.5
SLONIN JONATHAN Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.25
Quantity 2,836 -2.9%
Value US$80,117
3.5
SLONIN JONATHAN Officer Officer
Transaction date
Proposed sale
Price
28.25
Quantity 2,836
Value US$80,117
3.4
GAUGLER DARYL Officer Officer
Transaction date
Proposed sale
Price
28.38
Quantity 1,000
Value US$28,380
3.2
WILLIAMS KRISTEN Officer Officer
Transaction date
Proposed sale
Price
28.38
Quantity 7,452
Value US$211,488
2.8
HASTINGS PAUL J Director Non-Executive Director
Transaction date
Proposed sale
Price
28.38
Quantity 880
Value US$24,974
3.2
WILLIAMS KRISTEN Chief Administrative Officer Officer
Transaction date
Planned sale
Price
28.38
Quantity 7,452 -6.8%
Value US$211,488
2.8
HASTINGS PAUL J Non-Executive Director
Transaction date
Planned sale
Price
28.38
Quantity 880 -6.5%
Value US$24,974
3.4
GAUGLER DARYL Chief Operating Officer Officer
Transaction date
Planned sale
Price
28.38
Quantity 1,000 -0.9%
Value US$28,380
3.5
RIKER LAUREN Senior Vice President, Finance Officer
Transaction date
Planned sale
Price
28.72
Quantity 3,970 -9.4%
Value US$114,018
3.5
RIKER LAUREN Officer Officer
Transaction date
Proposed sale
Price
28.72
Quantity 3,970
Value US$114,005
3.5
SLONIN JONATHAN Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.57
Quantity 5,012 -10.1%
Value US$143,193
3.5
SLONIN JONATHAN Officer Officer
Transaction date
Proposed sale
Price
28.57
Quantity 5,012
Value US$143,193
4.0
PACE GARY W Non-Executive Director
Transaction date
Sale
Price
30.60
Quantity 90,000 -80.3%
Value US$2,754,000
4.0
PACE GARY W Non-Executive Director
Transaction date
Sale
Price
30.81
Quantity 28,257 -20.1%
Value US$870,598
4.0
PACE GARY W Non-Executive Director
Transaction date
Sale
Price
29.67
Quantity 1,066 -0.8%
Value US$31,628
4.0
PACE GARY W Board member
Transaction date
Proposed sale
Price
29.67
Quantity 120,483
Value US$3,575,000
3.7
WINSTON ROY Former Officer Officer
Transaction date
Proposed sale
Price
28.25
Quantity 31,000
Value US$875,858
3.7
WINSTON ROY Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.88
Quantity 509 -1.0%
Value US$17,751
3.7
WINSTON ROY Officer Officer
Transaction date
Proposed sale
Price
34.88
Quantity 509
Value US$17,752
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-12 PrS Proposed sale
Ceesay Abraham

Director

Non-Executive Director
57,431
18.82
US$3,822,308 		57,431 18.82 US$3,822,308
2026-06-12 2026-06-11 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
14,565 +5.3%
451.07
US$632,944 		14,565 +5.3% 451.07 US$632,944
2026-06-11 2026-06-11 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
14,853
15.98
US$936,686 		14,853 15.98 US$936,686
2026-06-05 2026-06-04 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
10,259 -5.8%
22.27
US$228,468 		10,259 -5.8% 22.27 US$228,468
2026-06-04 2026-06-04 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
10,259
22.27
US$228,468 		10,259 22.27 US$228,468
2026-04-24 2026-04-23 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
12,941 -10.9%
25.16
US$325,596 		12,941 -10.9% 25.16 US$325,596
2026-04-23 2026-04-23 PrS Proposed sale
Cross Shawn

Officer

Officer
12,941
25.16
US$325,576 		12,941 25.16 US$325,576
2026-04-22 2026-04-22 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
1,500 -1.4%
25.01
US$37,515 		1,500 -1.4% 25.01 US$37,515
2026-04-22 2026-04-22 PrS Proposed sale
Cross Shawn

Officer

Officer
1,500
25.01
US$37,520 		1,500 25.01 US$37,520
2026-04-22 2026-04-21 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
2,845 -2.6%
25.01
US$71,153 		2,845 -2.6% 25.01 US$71,153
2026-04-21 2026-04-21 PrS Proposed sale
Cross Shawn

Officer

Officer
2,845
25.01
US$71,149 		2,845 25.01 US$71,149
2026-04-22 2026-04-20 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
7,714 -6.8%
25.14
US$193,930 		7,714 -6.8% 25.14 US$193,930
2026-04-20 2026-04-20 PrS Proposed sale
Cross Shawn

Officer

Officer
7,714
25.14
US$193,912 		7,714 25.14 US$193,912
2026-03-19 2026-03-17 S Sale
3.2
Froimson Mark
Non-Executive Director
500 -2.4%
21.81
US$10,905 		500 -2.4% 21.81 US$10,905
2026-03-19 2026-03-17 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
3,261 -1.4%
22.82
US$74,416 		3,261 -1.4% 22.82 US$74,416
2026-03-17 2026-03-17 PrS Proposed sale
3.2
Froimson Mark

Director

Non-Executive Director
500
21.81
US$10,905 		500 21.81 US$10,905
2026-03-17 2026-03-17 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
3,261
22.82
US$74,416 		3,261 22.82 US$74,416
2026-02-03 2026-02-02 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
13,137 -9.1%
20.53
US$269,703 		13,137 -9.1% 20.53 US$269,703
2026-02-03 2026-02-02 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
4,000 -7.1%
20.81
US$83,240 		4,000 -7.1% 20.81 US$83,240
2026-02-03 2026-02-02 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
13,137 -9.1%
20.53
US$269,703 		13,137 -9.1% 20.53 US$269,703
2026-02-03 2026-02-02 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
4,000 -7.1%
20.81
US$83,240 		4,000 -7.1% 20.81 US$83,240
2026-02-02 2026-02-02 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
4,000
21.05
US$84,219 		4,000 21.05 US$84,219
2026-02-02 2026-02-02 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
13,137
20.53
US$269,703 		13,137 20.53 US$269,703
2026-01-06 2026-01-05 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
1,416 -2.3%
24.24
US$34,324 		1,416 -2.3% 24.24 US$34,324
2026-01-05 2026-01-05 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
1,416
24.24
US$34,324 		1,416 24.24 US$34,324
2025-12-11 2025-12-10 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
9,104 -13.9%
25.14
US$228,875 		9,104 -13.9% 25.14 US$228,875
2025-12-10 2025-12-10 PrS Proposed sale
Cross Shawn

Officer

Officer
9,104
25.14
US$228,912 		9,104 25.14 US$228,912
2025-12-11 2025-12-09 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
15,896 -22.0%
25.03
US$397,877 		15,896 -22.0% 25.03 US$397,877
2025-12-09 2025-12-09 PrS Proposed sale
Cross Shawn

Officer

Officer
15,896
25.03
US$397,837 		15,896 25.03 US$397,837
2025-11-19 2025-11-17 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
3,960 -2.2%
24.09
US$95,396 		3,960 -2.2% 24.09 US$95,396
2025-11-17 2025-11-17 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
3,960
24.09
US$95,396 		3,960 24.09 US$95,396
2025-11-13 2025-11-10 PlS Planned sale
Cross Shawn

Chief Financial Officer

Officer
12,060 -17.7%
22.09
US$266,405 		12,060 -17.7% 22.09 US$266,405
2025-11-10 2025-11-10 PrS Proposed sale
Cross Shawn

Officer

Officer
12,060
22.09
US$266,405 		12,060 22.09 US$266,405
2025-09-08 2025-09-04 PlS Planned sale
Ceesay Abraham
Non-Executive Director
2,354 -20.7%
27.19
US$64,005 		2,354 -20.7% 27.19 US$64,005
2025-09-04 2025-09-04 PrS Proposed sale
Ceesay Abraham

Director

Non-Executive Director
2,354
27.19
US$64,005 		2,354 27.19 US$64,005
2025-08-11 2025-08-07 S Sale
2.8
BIGAL MARCELO
Non-Executive Director
4,912 -30.1%
23.67
US$116,267 		4,912 -30.1% 23.67 US$116,267
2025-08-07 2025-08-07 PrS Proposed sale
2.8
BIGAL MARCELO

Director

Non-Executive Director
4,912
23.67
US$116,279 		4,912 23.67 US$116,279
2025-06-05 2025-06-04 S Sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
5,578 -8.6%
26.21
US$146,208 		5,578 -8.6% 26.21 US$146,208
2025-06-05 2025-06-04 S Sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
14,376 -8.2%
26.24
US$377,226 		14,376 -8.2% 26.24 US$377,226
2025-06-04 2025-06-04 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
5,579
26.21
US$146,209 		5,579 26.21 US$146,209
2025-06-04 2025-06-04 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
14,376
26.24
US$377,226 		14,376 26.24 US$377,226
2025-03-06 2025-03-06 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
500
23.25
US$11,625 		500 23.25 US$11,625
2025-01-06 2025-01-06 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
879
18.40
US$16,174 		879 18.40 US$16,174
2025-01-06 2025-01-06 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
879 -0.9%
18.40
US$16,174 		879 -0.9% 18.40 US$16,174
2024-12-16 2024-12-13 PlS Planned sale
3.4
GAUGLER DARYL

Chief Operating Officer

Officer
500 -0.4%
19.76
US$9,880 		500 -0.4% 19.76 US$9,880
2024-12-13 2024-12-13 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
500
19.76
US$9,880 		500 19.76 US$9,880
2024-09-13 2024-09-13 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
500
12.86
US$6,430 		500 12.86 US$6,430
2024-09-13 2024-09-13 PlS Planned sale
3.4
GAUGLER DARYL

Chief Operating Officer

Officer
500 -0.4%
12.86
US$6,430 		500 -0.4% 12.86 US$6,430
2024-08-19 2024-08-16 B Purchase
3.1
Brege Laura
Non-Executive Director
1,000 +6.0%
12.81
US$12,810 		1,000 +6.0% 12.81 US$12,810
2024-08-19 2024-08-16 B Purchase
2.8
BIGAL MARCELO
Non-Executive Director
1,512 +17.5%
13.25
US$20,034 		1,512 +17.5% 13.25 US$20,034
2024-08-14 2024-08-14 B Purchase
3.3
YANG MICHAEL J.
Non-Executive Director
2,000 +38.2%
12.90
US$25,800 		2,000 +38.2% 12.90 US$25,800
2024-08-13 2024-08-12 B Purchase
3.7
Lee Frank D.

Chief Executive Officer

Executive Director
8,264 +8.3%
12.10
US$99,994 		8,264 +8.3% 12.10 US$99,994
2024-08-12 2024-08-12 B Purchase
3.2
Froimson Mark
Non-Executive Director
1,400 +10.7%
11.58
US$16,212 		1,400 +10.7% 11.58 US$16,212
2024-08-12 2024-08-12 B Purchase
2.8
BIGAL MARCELO
Non-Executive Director
3,400 +65.0%
12.01
US$40,834 		3,400 +65.0% 12.01 US$40,834
2024-08-02 2024-08-02 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
945
20.05
US$18,947 		945 20.05 US$18,947
2024-08-02 2024-08-02 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
945 -1.0%
20.05
US$18,947 		945 -1.0% 20.05 US$18,947
2024-07-03 2024-07-02 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
2,836 -2.9%
28.25
US$80,117 		2,836 -2.9% 28.25 US$80,117
2024-07-02 2024-07-02 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
2,836
28.25
US$80,117 		2,836 28.25 US$80,117
2024-06-13 2024-06-13 PrS Proposed sale
3.4
GAUGLER DARYL

Officer

Officer
1,000
28.38
US$28,380 		1,000 28.38 US$28,380
2024-06-13 2024-06-13 PrS Proposed sale
3.2
WILLIAMS KRISTEN

Officer

Officer
7,452
28.38
US$211,488 		7,452 28.38 US$211,488
2024-06-13 2024-06-13 PrS Proposed sale
2.8
HASTINGS PAUL J

Director

Non-Executive Director
880
28.38
US$24,974 		880 28.38 US$24,974
2024-06-13 2024-06-13 PlS Planned sale
3.2
WILLIAMS KRISTEN

Chief Administrative Officer

Officer
7,452 -6.8%
28.38
US$211,488 		7,452 -6.8% 28.38 US$211,488
2024-06-13 2024-06-13 PlS Planned sale
2.8
HASTINGS PAUL J
Non-Executive Director
880 -6.5%
28.38
US$24,974 		880 -6.5% 28.38 US$24,974
2024-06-13 2024-06-13 PlS Planned sale
3.4
GAUGLER DARYL

Chief Operating Officer

Officer
1,000 -0.9%
28.38
US$28,380 		1,000 -0.9% 28.38 US$28,380
2024-06-13 2024-06-12 PlS Planned sale
3.5
RIKER LAUREN

Senior Vice President, Finance

Officer
3,970 -9.4%
28.72
US$114,018 		3,970 -9.4% 28.72 US$114,018
2024-06-12 2024-06-12 PrS Proposed sale
3.5
RIKER LAUREN

Officer

Officer
3,970
28.72
US$114,005 		3,970 28.72 US$114,005
2024-06-13 2024-06-11 PlS Planned sale
3.5
SLONIN JONATHAN

Chief Medical Officer

Officer
5,012 -10.1%
28.57
US$143,193 		5,012 -10.1% 28.57 US$143,193
2024-06-11 2024-06-11 PrS Proposed sale
3.5
SLONIN JONATHAN

Officer

Officer
5,012
28.57
US$143,193 		5,012 28.57 US$143,193
2024-03-08 2024-03-08 S Sale
4.0
PACE GARY W
Non-Executive Director
90,000 -80.3%
30.60
US$2,754,000 		90,000 -80.3% 30.60 US$2,754,000
2024-03-08 2024-03-07 S Sale
4.0
PACE GARY W
Non-Executive Director
28,257 -20.1%
30.81
US$870,598 		28,257 -20.1% 30.81 US$870,598
2024-03-08 2024-03-06 S Sale
4.0
PACE GARY W
Non-Executive Director
1,066 -0.8%
29.67
US$31,628 		1,066 -0.8% 29.67 US$31,628
2024-03-06 2024-03-06 PrS Proposed sale
4.0
PACE GARY W

Board member
120,483
29.67
US$3,575,000 		120,483 29.67 US$3,575,000
2023-11-13 2023-11-10 PrS Proposed sale
3.7
WINSTON ROY

Former Officer

Officer
31,000
28.25
US$875,858 		31,000 28.25 US$875,858
2023-08-04 2023-08-02 PlS Planned sale
3.7
WINSTON ROY

Chief Medical Officer

Officer
509 -1.0%
34.88
US$17,751 		509 -1.0% 34.88 US$17,751
2023-08-02 2023-08-02 PrS Proposed sale
3.7
WINSTON ROY

Officer

Officer
509
34.88
US$17,752 		509 34.88 US$17,752
Explore more

More insider trading research around Pacira Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America